Steven E Kempers MD

Dermatology•New Brighton, MN

Physician

Join to View Full Profile

119 14th Street NW, Suite 250New Brighton, MN 55112
Phone+1 763-571-4200
Fax+1 763-571-7202

Education & Training

University of MinnesotaResidency, Dermatology, 1986 - 1989
Santa Barbara Cottage HospitalInternship, Internal Medicine, 1985 - 1986
Perelman School of Medicine at the University of PennsylvaniaClass of 1985

Certifications & Licensure

CA State Medical License 1986 - 2026
MN State Medical License 1986 - 2026
NY State Medical License 2024 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Start of enrollment: 2007 May 07
Completed
Phase 2
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris Start of enrollment: 2007 Feb 01
Completed
Phase 3
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2007 Jan 01
Completed
Phase 2
Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
Completed
Phase 4
Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 Mar 01
Completed
Phase 3
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2011 Jul 01
Completed
Phase 2
Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis Start of enrollment: 2013 Mar 01
Completed
Phase 2
VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities Start of enrollment: 2014 May 01
Completed
Phase 3
Twelve Month Follow-Up of CP0108 Start of enrollment: 2014 Aug 01
Completed
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat Start of enrollment: 2016 Dec 22
Completed
Phase 2
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris
Journal of the American Academy of Dermatology. 2024-08-01
1 citations
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid
Science Advances. 2024-05-03
7 citations
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani
The British Journal of Dermatology. 2023-09-15

Journal Articles

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis
Andrew Blauvelt, Steven Kempers, Stephen Tyring, Glynis Ablon, The New England Journal of Medicine
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Leon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine

Authored Content

Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Steven E Kempers MD

Dr. Kempers is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Authored Content

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.